Making ...

VIVES

is an investment fund initiated by UCLouvain which

 

CHALLENGES

SUPPORTS

STRENGTHENS

PERPETUATES

 

your business projects

Key figures

Founded in
2004
Size of the last Fund
43 M €
Investments made
27
Exit
7
Total funds raised
268 M €
Direct jobs created
370

Portfolio

VIVES is a multi-sector fund that invests in projects with a positive societal impact

Syndesi Therapeutics is building upon a rich legacy of research on SV2A conducted at UCB. UCB identified novel modulators of SV2A that show pro-cognitive properties in preclinical models.

With the...

Botalys has developed a technology (vertical farming) that allows to produce rare plants and ingredients for the food supplement, cosmetics and pharmacy industries. Vertical farming allows them to...

iTeos Therapeutics targets the tumor microenvironment to boost immune cell efficiency in cancer eradication.

Immunotherapy is a revolutionary approach to cancer treatment that aims to educate the...